Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Change in Accured Expenses (2014 - 2026)

Lantheus Holdings (LNTH) posted quarterly Change in Accured Expenses of $23.0 million for Q1 2026, up 591.23% year-over-year from $3.3 million in Q1 2025, and up 15.89% quarter-over-quarter from $19.8 million in Q4 2025.

Lantheus Holdings (LNTH) Change in Accured Expenses (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has reported Change in Accured Expenses for 13 consecutive years, with $23.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 591.23% year-over-year to $23.0 million; the TTM figure through Mar 2026 stood at $10.6 million (up 3092.66% YoY), while the FY2025 annual figure was -$9.1 million, down 119.42% from the prior year.
  • Change in Accured Expenses improved to $23.0 million in Q1 2026 per LNTH's latest filing, from $19.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $50.4 million in Q1 2024 and bottomed at -$123.8 million in Q2 2023.
  • Historically, Change in Accured Expenses has averaged $2.5 million across 5 years, with a median of $8.1 million in 2023.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 1237.99% — and 2025, when it tumbled 1553.76%.
  • Lantheus Holdings' Change in Accured Expenses stood at $33.2 million in 2022, then slumped by 75.66% to $8.1 million in 2023, then jumped by 249.39% to $28.2 million in 2024, then fell by 29.7% to $19.8 million in 2025, then advanced by 15.89% to $23.0 million in 2026.
  • Business Quant data shows LNTH's Change in Accured Expenses at $23.0 million in Q1 2026, $19.8 million in Q4 2025, and -$26.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 82.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 142.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -219.00 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -4.00 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -8.50 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn -1.99 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.99 Mn
Jun 30, 2026 -1.99 Mn
Mar 31, 2026 23.00 Mn
Mar 31, 2026 23.00 Mn
Dec 31, 2025 19.85 Mn
Dec 31, 2025 19.85 Mn
Sep 30, 2025 -26.31 Mn
Sep 30, 2025 -26.31 Mn
Jun 30, 2025 -5.95 Mn
Jun 30, 2025 -5.95 Mn
Mar 31, 2025 3.33 Mn
Mar 31, 2025 3.33 Mn
Dec 31, 2024 28.24 Mn
Dec 31, 2024 28.24 Mn
Sep 30, 2024 1.81 Mn
Sep 30, 2024 1.81 Mn
Jun 30, 2024 -33.73 Mn
Jun 30, 2024 -33.73 Mn
Mar 31, 2024 50.45 Mn
Mar 31, 2024 50.45 Mn